ISDA

Entry Detail

PDB ID:

5T6H

Keywords:

Title:

Crystal structure of Aspergillus fumigatus N-myristoyl transferase in complex with myristoyl CoA and a dimethylpyridyl-dipihenyl-pyridine ligand

Biological Source:

Source Organism:

Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2016-09-01

Release Date:

2017-09-13

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.21

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Glycylpeptide N-tetradecanoyltransferase
Chain IDs:A
Chain Length:411
Number of Molecules:1
Biological Source:Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)

UniProt ID:Q9UVX3 Pfam ID:PF01233, PF02799 EC:2.3.1.97

Ligand Molecules

75Q

MYA

Primary Citation

Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.

Bayliss, T, Robinson, D.A, Smith, V.C, Brand, S, McElroy, S.P, Torrie, L.S, Mpamhanga, C, Norval, S, Stojanovski, L, Brenk, R, Frearson, J.A, Read, K.D, Gilbert, I.H, Wyatt, P.G.Show

J. Med. Chem. 60 9790 9806 (2017)

PMID: 29125744 DOI: 10.1021/acs.jmedchem.7b01255

Abstact

N-Myristoyltransferase (NMT) represents a promising drug target within the parasitic protozoa Trypanosoma brucei (T. brucei), the causative agent for human African trypanosomiasis (HAT) or sleeping sickness. We have previously validated T. brucei NMT as a promising druggable target for the treatment of HAT in both stages 1 and 2 of the disease. We report on the use of the previously reported DDD85646 (1) as a starting point for the design of a class of potent, brain penetrant inhibitors of T. brucei NMT.

Legend

Protein

Chemical

Disease

Primary Citation of related structures